CG Oncology (CGON) Leases: 2023-2025
Historic Leases for CG Oncology (CGON) over the last 2 years, with Sep 2025 value amounting to $4.2 million.
- CG Oncology's Leases rose 1428.36% to $4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year increase of 1428.36%. This contributed to the annual value of $221,000 for FY2024, which is 47.63% down from last year.
- Per CG Oncology's latest filing, its Leases stood at $4.2 million for Q3 2025, which was up 335.54% from $965,000 recorded in Q2 2025.
- CG Oncology's Leases' 5-year high stood at $4.2 million during Q3 2025, with a 5-year trough of $221,000 in Q4 2024.
- Moreover, its 3-year median value for Leases was $395,000 (2023), whereas its average is $977,000.
- In the last 5 years, CG Oncology's Leases slumped by 47.63% in 2024 and then spiked by 1,428.36% in 2025.
- Quarterly analysis of 3 years shows CG Oncology's Leases stood at $422,000 in 2023, then crashed by 47.63% to $221,000 in 2024, then spiked by 1,428.36% to $4.2 million in 2025.
- Its last three reported values are $4.2 million in Q3 2025, $965,000 for Q2 2025, and $1.0 million during Q1 2025.